Europe Platelet Rich Plasma (prp) Market Size & Outlook

The platelet rich plasma (prp) market in Europe is expected to reach a projected revenue of US$ 450.4 million by 2030. A compound annual growth rate of 16% is expected of Europe platelet rich plasma (prp) market from 2024 to 2030.
Revenue, 2023 (US$M)
$159.3
Forecast, 2030 (US$M)
$450.4
CAGR, 2024 - 2030
16%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe platelet rich plasma (prp) market, 2018-2030 (US$M)

Europe platelet rich plasma (prp) market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe platelet rich plasma (prp) market highlights

  • The Europe platelet rich plasma (prp) market generated a revenue of USD 159.3 million in 2023.
  • The market is expected to grow at a CAGR of 16% from 2024 to 2030.
  • In terms of segment, pure prp was the largest revenue generating type in 2023.
  • Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 159.3 million
Market revenue in 2030USD 450.4 million
Growth rate16% (CAGR from 2023 to 2030)
Largest segmentPure prp
Fastest growing segmentLeukocyte Rich PRP
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPure PRP, Leukocyte Rich PRP
Key market players worldwideJohnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences


Other key industry trends

  • In terms of revenue, Europe region accounted for 24.6% of the global platelet rich plasma (prp) market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 399.9 million by 2030.

Pure prp was the largest segment with a revenue share of 51.73% in 2023. Horizon Databook has segmented the Europe platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.


Europe is the second-largest PRP market globally and is anticipated to witness promising growth during the forecast period. This can be attributed to the rising demand for PRP therapy for sports injuries. In addition, expanding applications of PRP therapy, rapid technological advancements, and progressive demographic aging of the older population contribute to the market growth in Europe.

PRP therapy is regulated under Directive 2001/83/EC of the Council of November 6, 2001, and the European Parliament across the EU. This directive is further adapted by each member as per their regulatory framework. In some European countries, PRP products are considered blood derivatives, as the directive has not been translated into national law across Europe.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Platelet Rich Plasma (PRP) Market Companies

Name Profile # Employees HQ Website
Celling Biosciences View profile - -
APEX Biologix View profile 11-50 Murray, Utah, United States, North America https://apexbiologix.com
Juventix Regenerative Medical View profile 11-50 Tampa, Florida, United States, North America https://juventix.com/
Dr. PRP USA View profile 11-50 Stafford, Texas, United States, North America https://www.drprpusa.com
EmCyte Corporation View profile 11-50 Fort Myers, Florida, United States, North America https://emcyte.com/
Arthrex View profile 5001-10000 Naples, Florida, United States, North America https://www.arthrex.com/
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Europe platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)

Europe Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)

Europe platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online